A variety of inflammatory cells (such as classical monocytes and granulocytes) displayed overexpression of S100A8/A9, and increased serum levels of these molecules have been observed in other infectious diseases (e.g., COVID‐19) [14]. This evidence concerns the gene S100A8 and COVID-19.